Clinical Trials Directory

Trials / Completed

CompletedNCT06011616

Effects of Upperlimb Sensorimotor Training in Hemiplegic Cerebral Palsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Riphah International University · Academic / Other
Sex
All
Age
8 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The study aims to determine the effects of upper limb sensorimotor training as compared to task oriented raining in subjects with cerebral palsy. The study will target the upperlimb functions using multiple outcomes and will find the changes in subjects undergoing sensorimotor or task oriented training.

Detailed description

The stduy will include subjects fulfilling the inclusion criteria, will be divided into 2 groups; interventional and control. The interventional group will be recieving sensorimotor training comprising of sensory activities and motor activities. The control group will be having motor activities in the form of task oriented training. The duration of intervention would be 40 minutes in each group, 3 days a week, for 8 weeks.

Conditions

Interventions

TypeNameDescription
OTHERSensory trainingsensory training includes superficial sensory and deep sensory activities i.e. play with dough, painting with finger, recognizing objects with blocked vision, recognizing the drawn figure on palm, oint compression, bearing the weight on the paretic hand, leaning on the paretic side, walking with hand, rolling the heavy objects, dough squeezing etc.
OTHERMotor trainingMotor training would involve activitoes such as throwing and catching a ball, targeted ball throwing, hand in hand ball transferring, ball rolling, hitting a ball to ground and wall, hand roller etc.
OTHERConventional exercisesstretching exercises, muscle strengthening exercises, static weight bearing exercises, positioning

Timeline

Start date
2023-09-20
Primary completion
2024-01-20
Completion
2024-01-25
First posted
2023-08-25
Last updated
2024-01-30

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06011616. Inclusion in this directory is not an endorsement.